Cargando…

Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis

Background and Aims: Hepatocyte growth factor (HGF) is a multifunctional pleiotropic protein involved in tissue regeneration, protection, angiogenesis, anti-inflammatory and anti-fibrotic responses, and tumorigenesis, through binding to its receptor MET. Recombinant HGF protein has been shown to mit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yoon Mee, Fukui, Masato, Wang, Zhijun, Miao, Fiona, Karriker, Margo J., Seki, Ekihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064873/ https://www.ncbi.nlm.nih.gov/pubmed/30083132 http://dx.doi.org/10.3389/fendo.2018.00378

Ejemplares similares

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
por: Luci, Carmelo, et al.
Publicado: (2020)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
por: Tillman, Erik J., et al.
Publicado: (2020)

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
por: Dennis, Andrea, et al.
Publicado: (2021)

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
por: Pellegrina, Diogo, et al.
Publicado: (2023)

Acrolein, a New Villain in the Development of Alcoholic Liver Disease
por: Seki, Ekihiro
Publicado: (2016)

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
por: Li, Xinzhi, et al.
Publicado: (2022)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
por: Lan, Tian, et al.
Publicado: (2022)

Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
por: Koh, Eun Hee, et al.
Publicado: (2021)

Corticotropin releasing hormone is present in the feline placenta and maternal serum
por: Watt, Madison, et al.
Publicado: (2023)

Key hepatic signatures of human and mouse nonalcoholic steatohepatitis: A transcriptome–proteome data meta-analysis
por: Pyo, Jeong Joo, et al.
Publicado: (2022)

Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
por: Overi, Diletta, et al.
Publicado: (2020)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
por: Hwang, Seonghwan, et al.
Publicado: (2021)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
por: Yue, Si-Ran, et al.
Publicado: (2022)

Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
por: Pohl, Rebekka, et al.
Publicado: (2022)

Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues
por: Singla, Tanvi, et al.
Publicado: (2023)

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence
por: Yabiku, Koichi
Publicado: (2021)

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis
por: Zhang, Jun-jie, et al.
Publicado: (2023)

Neurotropin Suppresses Inflammatory Cytokine Expression and Cell Death through Suppression of NF-κB and JNK in Hepatocytes
por: Zhang, Bi, et al.
Publicado: (2014)

Alcoholic liver disease: A current molecular and clinical perspective()
por: Ohashi, Koichiro, et al.
Publicado: (2018)

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
por: Kim, Kook Hwan, et al.
Publicado: (2018)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review
por: Yaqub, Sayma, et al.
Publicado: (2021)

Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice
por: Nan, YueMin, et al.
Publicado: (2010)

Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma
por: Fang, Jia-Zhu, et al.
Publicado: (2015)

Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis
por: Kwan, Raymond, et al.
Publicado: (2017)

AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line
por: Yehezkel, Adi S., et al.
Publicado: (2023)

Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Hirsova, Petra, et al.
Publicado: (2021)

Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation
por: Wang, Qinglan, et al.
Publicado: (2020)

Workup and Management of Recurrent Attacks of Post-bariatric Hypoglycemia in a Patient With Non-alcoholic Steatohepatitis
por: Pokhriyal, Sindhu C, et al.
Publicado: (2023)

Poor glycaemic control and ectopic fat deposition mediates the increased risk of non-alcoholic steatohepatitis in high-risk populations with type 2 diabetes: Insights from Bayesian-network modelling
por: Waddell, T., et al.
Publicado: (2023)

Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
por: Pan, Chelsea S., et al.
Publicado: (2020)

Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis
por: Ye, Jianzhong, et al.
Publicado: (2020)

Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis
por: Li, Xiaoya, et al.
Publicado: (2022)

Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2020)

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
por: Ishikawa, Hisashi, et al.
Publicado: (2014)

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
por: Liang, Ning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_93mpvrpkug1hs6jp5jfjeir68l